Development of Injectable Calcium Sulfate and Self-Setting Calcium Phosphate Composite Bone Graft Materials for Minimally Invasive Surgery

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Jul 27

PMID 35886941

Authors

Yu-Hsun Chiu

I-Cheng Chen

Chen-Ying Su

Hsin-Hua Tsai

Tai-Horng Young

Hsu-Wei Fang

Affiliations

Soon will be listed here.

Abstract

The demand of bone grafting is increasing as the population ages worldwide. Although bone graft materials have been extensively developed over the decades, only a few injectable bone grafts are clinically available and none of them can be extruded from 18G needles. To overcome the existing treatment limitations, the aim of this study is to develop ideal injectable implants from biomaterials for minimally invasive surgery. An injectable composite bone graft containing calcium sulfate hemihydrate, tetracalcium phosphate, and anhydrous calcium hydrogen phosphate (CSH/CaP paste) was prepared with different CSH/CaP ratios and different concentrations of additives. The setting time, injectability, mechanical properties, and biocompatibility were evaluated. The developed injectable CSH/CaP paste (CSH/CaP 1:1 supplemented with 6% citric acid and 2% HPMC) presented good handling properties, great biocompatibility, and adequate mechanical strength. Furthermore, the paste was demonstrated to be extruded from a syringe equipped with 18G needles and exerted a great potential for minimally invasive surgery. The developed injectable implants with tissue repairing potentials will provide an ideal therapeutic strategy for minimally invasive surgery to apply in the treatment of maxillofacial defects, certain indications in the spine, inferior turbinate for empty nose syndrome (ENS), or reconstructive rhinoplasty.

Citing Articles

Potential role of calcium sulfate/β-tricalcium phosphate/graphene oxide nanocomposite for bone graft application_mechanical and biological analyses.

Lu Y, Chang T, Lin T, Yeh S, Lin H, Cheng Q J Orthop Surg Res. 2024; 19(1):644.

PMID: 39396014 PMC: 11470679. DOI: 10.1186/s13018-024-05142-8.

Limitations and modifications in the clinical application of calcium sulfate.

Lun D, Li S, Li N, Mou L, Li H, Zhu W Front Surg. 2024; 11:1278421.

PMID: 38486794 PMC: 10937423. DOI: 10.3389/fsurg.2024.1278421.

Biomaterial scaffolds in maxillofacial bone tissue engineering: A review of recent advances.

Huang X, Lou Y, Duan Y, Liu H, Tian J, Shen Y Bioact Mater. 2023; 33:129-156.

PMID: 38024227 PMC: 10665588. DOI: 10.1016/j.bioactmat.2023.10.031.

Design and Manufacture of Bone Cements Based on Calcium Sulfate Hemihydrate and Mg, Sr-Doped Bioactive Glass.

Moazeni N, Hesaraki S, Behnamghader A, Esmaeilzadeh J, Orive G, Dolatshahi-Pirouz A Biomedicines. 2023; 11(10).

PMID: 37893206 PMC: 10604917. DOI: 10.3390/biomedicines11102833.

References

Liu H, Li H, Cheng W, Yang Y, Zhu M, Zhou C . Novel injectable calcium phosphate/chitosan composites for bone substitute materials. Acta Biomater. 2006; 2(5):557-65. DOI: 10.1016/j.actbio.2006.03.007. View

Boyle K, Sosa B, Osagie L, Turajane K, Bostrom M, Yang X . Vancomycin-laden calcium phosphate-calcium sulfate composite allows bone formation in a rat infection model. PLoS One. 2019; 14(9):e0222034. PMC: 6752756. DOI: 10.1371/journal.pone.0222034. View

Zhang J, Liu W, Schnitzler V, Tancret F, Bouler J . Calcium phosphate cements for bone substitution: chemistry, handling and mechanical properties. Acta Biomater. 2013; 10(3):1035-49. DOI: 10.1016/j.actbio.2013.11.001. View

Passali D, La Rosa R, Passali G, Ciprandi G . The Empty Nose Syndrome: a pragmatic classification in clinical practice. Acta Biomed. 2021; 92(5):e2021288. PMC: 8689295. DOI: 10.23750/abm.v92i5.9835. View

Wang W, Yeung K . Bone grafts and biomaterials substitutes for bone defect repair: A review. Bioact Mater. 2018; 2(4):224-247. PMC: 5935655. DOI: 10.1016/j.bioactmat.2017.05.007. View

Chen Z, Liu H, Liu X, Lian X, Guo Z, Jiang H . Improved workability of injectable calcium sulfate bone cement by regulation of self-setting properties. Mater Sci Eng C Mater Biol Appl. 2013; 33(3):1048-53. DOI: 10.1016/j.msec.2012.11.019. View

Leong S . The clinical efficacy of surgical interventions for empty nose syndrome: A systematic review. Laryngoscope. 2015; 125(7):1557-62. DOI: 10.1002/lary.25170. View

Lamb M, Bacon D, Zeatoun A, Onourah P, Thorp B, Abramowitz J . Mental health burden of empty nose syndrome compared to chronic rhinosinusitis and chronic rhinitis. Int Forum Allergy Rhinol. 2022; 12(11):1340-1349. DOI: 10.1002/alr.22997. View

Burguera E, Xu H, Weir M . Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate. J Biomed Mater Res B Appl Biomater. 2005; 77(1):126-34. DOI: 10.1002/jbm.b.30403. View

10.

Bergmark R, Gray S . Surgical Management of Turbinate Hypertrophy. Otolaryngol Clin North Am. 2018; 51(5):919-928. DOI: 10.1016/j.otc.2018.05.008. View

11.

Ishikawa K, Miyamoto Y, Kon M, Nagayama M, Asaoka K . Non-decay type fast-setting calcium phosphate cement: composite with sodium alginate. Biomaterials. 1995; 16(7):527-32. DOI: 10.1016/0142-9612(95)91125-i. View

12.

Thai V, Lee B . Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using hydroxy-propyl-methyl-cellulose and citric acid. J Mater Sci Mater Med. 2010; 21(6):1867-74. PMC: 2882049. DOI: 10.1007/s10856-010-4058-9. View

13.

Liu W, Zhang J, Weiss P, Tancret F, Bouler J . The influence of different cellulose ethers on both the handling and mechanical properties of calcium phosphate cements for bone substitution. Acta Biomater. 2012; 9(3):5740-50. DOI: 10.1016/j.actbio.2012.11.020. View

14.

Cherng A, Takagi S, Chow L . Effects of hydroxypropyl methylcellulose and other gelling agents on the handling properties of calcium phosphate cement. J Biomed Mater Res. 1997; 35(3):273-7. DOI: 10.1002/(sici)1097-4636(19970605)35:3<273::aid-jbm1>3.0.co;2-e. View

15.

Thomas M, Puleo D . Calcium sulfate: Properties and clinical applications. J Biomed Mater Res B Appl Biomater. 2008; 88(2):597-610. DOI: 10.1002/jbm.b.31269. View

16.

Larsson S, Hannink G . Injectable bone-graft substitutes: current products, their characteristics and indications, and new developments. Injury. 2011; 42 Suppl 2:S30-4. DOI: 10.1016/j.injury.2011.06.013. View

17.

Schlickewei C, Laaff G, Andresen A, Klatte T, Rueger J, Ruesing J . Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite--an animal model. J Orthop Surg Res. 2015; 10:116. PMC: 4513618. DOI: 10.1186/s13018-015-0263-z. View

18.

Moseke C, Gbureck U . Tetracalcium phosphate: Synthesis, properties and biomedical applications. Acta Biomater. 2010; 6(10):3815-23. DOI: 10.1016/j.actbio.2010.04.020. View

19.

Laurencin C, Khan Y, El-Amin S . Bone graft substitutes. Expert Rev Med Devices. 2005; 3(1):49-57. DOI: 10.1586/17434440.3.1.49. View

20.

Blouin S, Moreau M, Weiss P, Daculsi G, Basle M, Chappard D . Evaluation of an injectable bone substitute (betaTCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely osteopenic and aged rats. J Biomed Mater Res A. 2006; 78(3):570-80. DOI: 10.1002/jbm.a.30721. View